Chloe Brown

ORCID: 0009-0007-4051-5497
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Respiratory viral infections research
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 detection and testing
  • Child Nutrition and Feeding Issues
  • SARS-CoV-2 and COVID-19 Research
  • Tracheal and airway disorders
  • Genetics and Neurodevelopmental Disorders
  • Genomic variations and chromosomal abnormalities
  • COVID-19 Clinical Research Studies
  • Bacteriophages and microbial interactions
  • Prion Diseases and Protein Misfolding
  • Amino Acid Enzymes and Metabolism

Michigan Department of Health and Human Services
2023-2024

University of Birmingham
2021

Roslin Institute
2015

Biotechnology and Biological Sciences Research Council
2015

Beginning the week of December 19-25, 2021, B.1.1.529 (Omicron) variant SARS-CoV-2 (the virus that causes COVID-19) became predominant circulating in United States (i.e., accounted for >50% sequenced isolates).* Information on impact booster or additional doses COVID-19 vaccines have preventing hospitalizations during Omicron predominance is limited. Data from COVID-19-Associated Hospitalization Surveillance Network (COVID-NET)† were analyzed to compare COVID-19-associated hospitalization...

10.15585/mmwr.mm7112e2 article EN MMWR Morbidity and Mortality Weekly Report 2022-03-18

Abstract Background Sleep disorders are common in people with intellectual disability (ID) and autism, growing evidence of diverse sleep profiles across ID associated genetic syndromes. Documenting the prevalence profile specific syndromes will quantify syndrome-driven ‘risk’, inform prognosis enhance understanding aetiology disorders. Method Following PRISMA guidelines for meta-analysis, we searched Ovid PsycINFO, MEDLINE, Embase, Web Science PubMed Central use syndrome-specific keywords 60...

10.1186/s13229-021-00426-w article EN cc-by Molecular Autism 2021-02-25

Importance Respiratory syncytial virus (RSV) infection can cause severe illness in adults. However, there is considerable uncertainty the burden of RSV-associated hospitalizations among adults prior to RSV vaccine introduction. Objective To describe demographic characteristics hospitalized with laboratory-confirmed and estimate annual rates numbers hospitalizations, intensive care unit (ICU) admissions, in-hospital deaths. Design, Setting, Participants This cross-sectional study used data...

10.1001/jamanetworkopen.2024.44756 article EN cc-by-nc-nd JAMA Network Open 2024-11-13

Introduction: Respiratory syncytial virus (RSV) can cause severe illness among older adults, but potential cardiac complications have not been comprehensively described. We evaluated the frequency and severity of acute events adults hospitalized with laboratory-confirmed RSV to inform recommendations for vaccine candidates in development. Methods: The RSV-Associated Hospitalization Surveillance Network (RSV-NET) abstracted medical record data all patients identified infection...

10.1161/circ.148.suppl_1.11882 article EN Circulation 2023-11-07
Coming Soon ...